Anthracene-Based Pyrano[2,3- c ]Pyrazole Derivatives: Synthesis, Selective Antitumor Activity, Mechanistic Insights, and In Silico Evaluation

The development of selective anticancer agents with minimal toxicity toward normal cells remains a major challenge in cancer therapy. Targeting key regulators of apoptosis and cell-cycle progression, such as Bcl-2 and CDK2, represents a potential strategy for anticancer drug discovery. In this study, a series of newly synthesized anthracene-based heterocyclic derivatives was evaluated through integrated experimental and computational approaches. The quantitative purity of potent compounds 3 and 5 was ensured with HPLC analysis. Cytotoxicity was assessed against human HepG2 hepatocellular carcinoma and WI-38 normal lung fibroblast cells, and IC50 values and selectivity indices (SI) were determined. Compounds 3 and 5 exhibited the highest cytotoxic activity against HepG2 cells, with IC50 values of 7.09 and 9.74 μM, respectively, and favorable SI values of approximately 4–5. Molecular docking was employed to explore the potential interactions of the synthesized compounds with Bcl-2 and CDK2, while Annexin V-FITC/PI staining and flow cytometry were used to investigate apoptosis and cell-cycle effects. Docking analysis indicated favorable predicted interactions of these compounds with Bcl-2 and CDK2 through hydrogen-bonding and hydrophobic contacts. Consistent with their cytotoxic effects, both compounds increased apoptotic cell populations, particularly compound 5, and increased the proportion of cells in the G0/G1 phase relative to untreated control, suggesting disruption of cell-cycle progression. ADME predictions indicated generally favorable drug-like properties for the synthesized compounds, particularly 3 and 5, including high gastrointestinal absorption and acceptable physicochemical characteristics. Overall, the combined biological and computational findings identify compounds 3 and 5 as hit compounds warranting further evaluation in a broader panel of cancer cell lines. The observed cellular effects and docking results provide a preliminary mechanistic rationale for the potential involvement of Bcl-2- and CDK2-associated pathways; however, direct target engagement and inhibition require further biochemical validation. Future studies should include broader cancer-cell panels, target-validation assays, and in vivo evaluation.

Authors

Institutions

Publication Details

Journal
Polycyclic aromatic compounds
Published
2026-11-13
DOI
https://doi.org/10.1080/10406638.2026.2759625
Primary Topic
Heterocyclic Compound Synthesis and Bioactivity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Anthracene-Based Pyrano[2,3- c ]Pyrazole Derivatives: Synthesis, Selective Antitumor Activity, Mechanistic Insights, and In Silico Evaluation

Eman A. E. El‐Helw, Budur Nuwayji Alanazi, Hoda A. Ahmed, Sayed K. Ramadan et al.
Polycyclic aromatic compounds
Heterocyclic Compound Synthesis and Bioactivity
article

Anthracene-Based Pyrano[2,3- c ]Pyrazole Derivatives: Synthesis, Selective Antitumor Activity, Mechanistic Insights, and In Silico Evaluation

Eman A. E. El‐Helw, Budur Nuwayji Alanazi, Hoda A. Ahmed, Sayed K. Ramadan, Ahmed Kamel El-Ziaty, Aya I. Hassaballah
article en

Abstract

The development of selective anticancer agents with minimal toxicity toward normal cells remains a major challenge in cancer therapy. Targeting key regulators of apoptosis and cell-cycle progression, such as Bcl-2 and CDK2, represents a potential strategy for anticancer drug discovery. In this study, a series of newly synthesized anthracene-based heterocyclic derivatives was evaluated through integrated experimental and computational approaches. The quantitative purity of potent compounds 3 and 5 was ensured with HPLC analysis. Cytotoxicity was assessed against human HepG2 hepatocellular carcinoma and WI-38 normal lung fibroblast cells, and IC50 values and selectivity indices (SI) were determined. Compounds 3 and 5 exhibited the highest cytotoxic activity against HepG2 cells, with IC50 values of 7.09 and 9.74 μM, respectively, and favorable SI values of approximately 4–5. Molecular docking was employed to explore the potential interactions of the synthesized compounds with Bcl-2 and CDK2, while Annexin V-FITC/PI staining and flow cytometry were used to investigate apoptosis and cell-cycle effects. Docking analysis indicated favorable predicted interactions of these compounds with Bcl-2 and CDK2 through hydrogen-bonding and hydrophobic contacts. Consistent with their cytotoxic effects, both compounds increased apoptotic cell populations, particularly compound 5, and increased the proportion of cells in the G0/G1 phase relative to untreated control, suggesting disruption of cell-cycle progression. ADME predictions indicated generally favorable drug-like properties for the synthesized compounds, particularly 3 and 5, including high gastrointestinal absorption and acceptable physicochemical characteristics. Overall, the combined biological and computational findings identify compounds 3 and 5 as hit compounds warranting further evaluation in a broader panel of cancer cell lines. The observed cellular effects and docking results provide a preliminary mechanistic rationale for the potential involvement of Bcl-2- and CDK2-associated pathways; however, direct target engagement and inhibition require further biochemical validation. Future studies should include broader cancer-cell panels, target-validation assays, and in vivo evaluation.

Polycyclic aromatic compounds
Princess Nourah bint Abdulrahman University (SA), Ain Shams University (EG), Yanbu University College (SA), Taibah University (SA)
Heterocyclic Compound Synthesis and Bioactivity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon